Biological Products, (No Diagnostic Substances) 8 companies · $81.60B combined revenue
SIC 2836 · official SEC filings
| # | Ticker | Company | Mkt Cap* | Revenue | Net Income | Sector |
|---|---|---|---|---|---|---|
| 1 | AMGN | Amgen Inc | $150.10B | $36.75B | $7.71B | Biological Products, (No Diagnostic Substances) |
| 2 | GILD | Gilead Sciences, Inc. | $103.20B | $29.44B | $8.51B | Biological Products, (No Diagnostic Substances) |
| 3 | BIIB | Biogen Inc. | $18.38B | $9.89B | $1.29B | Biological Products, (No Diagnostic Substances) |
| #4 | EXEL | Exelixis, Inc. | $9.40B | $2.32B | $782.57M | Biological Products, (No Diagnostic Substances) |
| #5 | MRNA | Moderna, Inc. | $9.90B | $1.94B | $-2.82B | Biological Products, (No Diagnostic Substances) |
| #6 | TECH | Bio-Techne Corp | $9.10B | $1.22B | $181.86M | Biological Products, (No Diagnostic Substances) |
| #7 | KYMR | Kymera Therapeutics, Inc. | $2.29B | $39.21M | $-311.35M | Biological Products, (No Diagnostic Substances) |
| #8 | TWST | Twist Bioscience Corp | $2.32B | – | $-77.67M | Biological Products, (No Diagnostic Substances) |